Four African countries have reported new cases of polio linked to the oral vaccine, as global health numbers show there are now more children being paralysed by viruses originating in vaccines than in the wild.
In a report late last week, the World Health Organization and partners noted nine new polio cases caused by the vaccine in Nigeria, Congo, Central African Republic and Angola. Seven countries elsewhere in Africa have similar outbreaks and cases have been reported in Asia, including the two countries where polio remains endemic, Afghanistan and Pakistan.
In rare cases, the live virus in oral polio vaccine can mutate into a form capable of sparking new outbreaks. All the current vaccine-derived polio cases have been sparked by a Type 2 virus contained in the vaccine. Type 2 wild virus was eliminated years ago.
Polio is a highly infectious disease that spreads in contaminated water or food and usually strikes children under 5. About one in 200 infections results in paralysis. Among those, a small percentage die when their breathing muscles are crippled.
Donors last week pledged USD 2.6 billion to combat polio as part of an eradication initiative that began in 1988 and hoped to wipe out polio by 2000. Since then, numerous such deadlines have been missed.
To eradicate polio, more than 95 per cent of a population needs to be immunised. WHO and partners have long relied on oral polio vaccines because they are cheap and can be easily administered, requiring only two drops per dose.
Western countries use a more expensive injectable polio vaccine that contains an inactivated virus incapable of causing polio.
The Independent Monitoring Board, a group set up by WHO to assess polio eradication, warned in a report this month that vaccine-derived polio virus is "spreading uncontrolled in West Africa, bursting geographical boundaries and raising fundamental questions and challenges for the whole eradication process."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
